🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label Phase 2 clinical trial to evaluate whether...
Status
Completed
Location
University of Alabama Hematology Oncology Clinic at Medical West
Start Date
2013-04
Trial ID
NCT01780545
This Phase II study has been designed to evaluate the anti-tumor effects of...
Status
Terminated
Location
Prostate Oncology Specialists, Inc.
Start Date
2012-12
Trial ID
NCT01681433
Treatments Being Tested
The primary objective of this study is to ascertain whether there is eviden...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2011-10
Trial ID
NCT01454089
Treatments Being Tested
This randomized phase II study will compare the efficacy and safety of the ...
Status
Completed
Location
Rocky Mountain Cancer Center
Start Date
2013-07
Trial ID
NCT01829113
The purpose of this study is to compare the overall survival in patients wi...
Status
Completed
Location
University of California-San Francisco
Start Date
2013-09
Trial ID
NCT01844817
This is a single centre, open label, phase I dose escalation trial using a ...
Status
Unknown
Location
The Prostate Centre at Vancouver General Hospital
Start Date
2009-07
Trial ID
NCT00959868
Treatments Being Tested
This study is for patients with cancer who have failed potentially curative...
Status
Completed
Location
Seattle Cancer Care Alliance
Start Date
2007-06
Trial ID
NCT00487786
This study is being offered to patients who have castrate-resistant (also k...
Status
Completed
Location
University of Washington/Seattle Cancer Care Alliance
Start Date
2010-09
Trial ID
NCT01120470
Treatments Being Tested
This study is being carried out to see if a new drug called Apatorsen in co...
Status
Unknown
Location
Royal Cornwall Hospitals NHS Trust
Start Date
2014-06
Trial ID
NCT02423590
Treatments Being Tested